ATE193650T1 - Verwendung von aromatischen steroiden, die in der 3-stelle bei einer disubstituierte-aminoalkoxy kette substituiert sind, zur herstellung eines medikaments zur kontrolle der fertilität, insbesondere männlicher fertilität - Google Patents

Verwendung von aromatischen steroiden, die in der 3-stelle bei einer disubstituierte-aminoalkoxy kette substituiert sind, zur herstellung eines medikaments zur kontrolle der fertilität, insbesondere männlicher fertilität

Info

Publication number
ATE193650T1
ATE193650T1 AT95400630T AT95400630T ATE193650T1 AT E193650 T1 ATE193650 T1 AT E193650T1 AT 95400630 T AT95400630 T AT 95400630T AT 95400630 T AT95400630 T AT 95400630T AT E193650 T1 ATE193650 T1 AT E193650T1
Authority
AT
Austria
Prior art keywords
fertility
disubstituted
medication
production
place
Prior art date
Application number
AT95400630T
Other languages
English (en)
Inventor
Armelle Bonfils
Daniel Philibert
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of ATE193650T1 publication Critical patent/ATE193650T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95400630T 1994-03-24 1995-03-22 Verwendung von aromatischen steroiden, die in der 3-stelle bei einer disubstituierte-aminoalkoxy kette substituiert sind, zur herstellung eines medikaments zur kontrolle der fertilität, insbesondere männlicher fertilität ATE193650T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9403460A FR2717690B1 (fr) 1994-03-24 1994-03-24 Application de stéroïdes aromatiques 3 substitués par un aminoalcoxy substitué à l'obtention d'un médicament pour contrôler la stérilité, notamment masculine.

Publications (1)

Publication Number Publication Date
ATE193650T1 true ATE193650T1 (de) 2000-06-15

Family

ID=9461385

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95400630T ATE193650T1 (de) 1994-03-24 1995-03-22 Verwendung von aromatischen steroiden, die in der 3-stelle bei einer disubstituierte-aminoalkoxy kette substituiert sind, zur herstellung eines medikaments zur kontrolle der fertilität, insbesondere männlicher fertilität

Country Status (16)

Country Link
US (5) US5554604A (de)
EP (1) EP0676202B1 (de)
JP (1) JP3678454B2 (de)
KR (1) KR100367805B1 (de)
CN (1) CN1055391C (de)
AT (1) ATE193650T1 (de)
AU (1) AU698349B2 (de)
CA (1) CA2145469A1 (de)
DE (1) DE69517356T2 (de)
DK (1) DK0676202T3 (de)
ES (1) ES2147267T3 (de)
FR (1) FR2717690B1 (de)
GR (1) GR3033882T3 (de)
HU (1) HUT72085A (de)
PT (1) PT676202E (de)
RU (1) RU2176506C2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742337B1 (fr) * 1995-12-13 1998-03-06 Roussel Uclaf Application du 3-alpha-hydroxy-5-alpha-androsta-16-ene a titre de medicaments
US5834225A (en) * 1997-01-15 1998-11-10 Board Of Trustees Operating Michigan State University Method, device and test kit for capacitation of sperm
DE19917930A1 (de) * 1999-04-15 2000-10-19 Schering Ag Ent-Steroide als selektiv wirksame Estrogene
JP2004518637A (ja) * 2000-11-03 2004-06-24 ワシントン・ユニバーシティ 細胞保護活性を有する修飾されたヒドロキシ置換芳香族構造体
US20020132802A1 (en) * 2000-11-17 2002-09-19 Washington Univeristy Cytoprotective polycyclic compounds
JP4045090B2 (ja) * 2001-11-06 2008-02-13 オムロン株式会社 静電アクチュエータの調整方法
US7687486B2 (en) * 2003-04-29 2010-03-30 Florida Agricultural & Mechanical University Selective estrogen receptor modulators
US10397672B2 (en) 2016-06-20 2019-08-27 Cable Television Laboratories, Inc. Systems and methods for intelligent edge to edge optical system and wavelength provisioning

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621301A (de) * 1961-08-11
FR1338308A (fr) * 1961-08-11 1963-09-27 Roussel Uclaf Stéroïdes aromatiques substitués en position 3 et procédé de préparation
GB984028A (en) * 1963-01-17 1965-02-24 Parke Davis & Co Estradiol derivatives and methods for their production
GB984029A (en) * 1963-01-17 1965-02-24 Parke Davis & Co Estrone derivatives and methods for their production
US3519714A (en) * 1966-03-15 1970-07-07 Herchel Smith Synthesis of gona-1,3,5(10)-trienes
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
SE8802402D0 (sv) * 1988-06-28 1988-06-28 Pharmacia Ab Novel esters
GB9226489D0 (en) * 1992-12-19 1993-02-10 Univ Manchester A joint
KR100984028B1 (ko) * 2008-01-06 2010-10-01 전현철 새콤달콤한 조성물을 난(卵)에 전이하여 구운 새로운 향미의 도포 난(卵) 제조방법
KR102037155B1 (ko) * 2018-11-28 2019-10-28 김훈 다중 레이어를 갖는 프라모델 완성품 보관 및 전시케이스

Also Published As

Publication number Publication date
DE69517356T2 (de) 2000-12-14
FR2717690A1 (fr) 1995-09-29
AU698349B2 (en) 1998-10-29
JP3678454B2 (ja) 2005-08-03
JPH07285988A (ja) 1995-10-31
AU1495695A (en) 1995-10-05
RU2176506C2 (ru) 2001-12-10
RU95104235A (ru) 1996-11-27
EP0676202B1 (de) 2000-06-07
DK0676202T3 (da) 2000-10-16
US5739124A (en) 1998-04-14
EP0676202A2 (de) 1995-10-11
CN1111988A (zh) 1995-11-22
KR100367805B1 (ko) 2003-08-02
DE69517356D1 (de) 2000-07-13
FR2717690B1 (fr) 1996-04-26
GR3033882T3 (en) 2000-11-30
EP0676202A3 (de) 1995-12-27
CA2145469A1 (fr) 1995-09-25
US5580864A (en) 1996-12-03
HU9500846D0 (en) 1995-05-29
HUT72085A (en) 1996-03-28
US5554604A (en) 1996-09-10
CN1055391C (zh) 2000-08-16
US5635498A (en) 1997-06-03
US5672595A (en) 1997-09-30
PT676202E (pt) 2000-09-29
ES2147267T3 (es) 2000-09-01
KR950031078A (ko) 1995-12-18

Similar Documents

Publication Publication Date Title
ES2089416T3 (es) Procedimiento de produccion de intermedios para uso en la produccion de alcoxiiminoacetamidas.
DE3870801D1 (de) Gallensaeure-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die sie enthalten.
DK0587088T3 (da) Substituerede cyclohexan-derivater, fremgangsmåde til deres fremstilling og anvendelsen af forbindelserne til behandling af sygdomme
ATE193650T1 (de) Verwendung von aromatischen steroiden, die in der 3-stelle bei einer disubstituierte-aminoalkoxy kette substituiert sind, zur herstellung eines medikaments zur kontrolle der fertilität, insbesondere männlicher fertilität
DE69123000D1 (de) Neue tricyclische Verbindung oder Salze davon, Verfahren zur Herstellung und antimikrobieller Wirkstoff, der sie enthält
ES2063852T3 (es) Supresion de la sintesis y secrecion de la hormona paratiroide con derivados de vitamina d3.
DE3865443D1 (de) 1-(4-hydroxy-3,5-di-tert.-butyl-benzoyl)-homopiperazin, verschiedene von dessen derivaten, verfahren zur herstellung dieser verbindungen, die sie enthaltenden arzneimittel und ihre verwendung.
ES2147907T3 (es) Nuevos acidos y esteres 2,2-dimetil-omega-fenoxi-alcanoicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2044405T3 (es) Un procedimiento para preparar una composicion de carboplatino.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
DE3852377D1 (de) Hepatocyt-stimulierender Faktor.
ATE67182T1 (de) Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3861926D1 (de) Polyzyklische aromatische verbindungen, verfahren zu deren herstellung, deren verwendung in menschlicher und tierischer medizin und in der kosmetik.
DE3869144D1 (de) 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amino-6h-1,3,4-thiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung.
ES2059756T3 (es) Composiciones farmaceuticas que contienen primicina.
HU9502177D0 (en) Piperazine derivatives for producing alkil-trazodone derivatives and process for producing them
ATE17570T1 (de) Neue 1,1,2-triphenyl-but-1-en-derivate, sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE157974T1 (de) Neue in 4-stellung durch aryl oder n-heteroaryl substituierte 2h-benzo(b>pyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
HU911649D0 (en) Process for producing heterocyclic nmda antagonists
DE69230274T2 (de) Verfahren zur Herstellung von Zwischenverbindungen für Vitamin-D-Derivate sowie Verbindungen
DE58906207D1 (de) Substituierte 2-Aminothiazole.
PT96178A (pt) Metodo para a utilizacao de naftoxazinas no tratamento de condicoes associadas com a esquemia cerebral
ATE32063T1 (de) Iminosulfonamide und verfahren zu ihrer herstellung, die pharmazeutische praeparate solche verbindungen enthalten, sowie die verbindungen zur verwendung.
ATE118774T1 (de) Verfahren zur herstellung von 4-alkoxyalkyl-beta- carbolinen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee